Tests Hint China's H7N9 Could Be Resistant To Tamiflu, Relenza Flu Drugs
This article was originally published in PharmAsia News
Executive Summary
One of the first of China's cases of the H7N9 avian influenza has demonstrated through gene sequencing a resistance to Roche's Tamiflu (oseltamivir) as well as a reduced sensitivity to GlaxoSmithKline's Relenza (zanamivir).